Drug Trial Radar · NCT00067938
Bipolar Study in Adults at Least 18 Years of Age
Last checked: Nov 19, 2026Latest source record: Sep 1, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Actual
Start
Aug 2003
Primary completion
Aug 2004
Study completion Aug 2004
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Sep 5, 2003
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Bipolar study of tolerability, clinical response and patient satisfaction
Conditions
- Bipolar Disorder
Interventions
lamotrigineDrug
Lamotrigine
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint will be the rate of rash during 12 weeks.Time frame: 12 Weeks
Locations
308 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Albertville, Alabama
GSK Investigational Site
Anniston, Alabama
GSK Investigational Site
Birmingham, Alabama
GSK Investigational Site
Birmingham, Alabama
GSK Investigational Site
Birmingham, Alabama
GSK Investigational Site
Fairhope, Alabama
GSK Investigational Site
Huntsville, Alabama
GSK Investigational Site
Tuscaloosa, Alabama
GSK Investigational Site
Chandler, Arizona
GSK Investigational Site
Phoenix, Arizona
GSK Investigational Site
Phoenix, Arizona
GSK Investigational Site
Phoenix, Arizona
GSK Investigational Site
Phoenix, Arizona
GSK Investigational Site
Rogers, Arizona
GSK Investigational Site
Tucson, Arizona
GSK Investigational Site
Fort Smith, Arkansas
GSK Investigational Site
Little Rock, Arkansas
GSK Investigational Site
North Little Rock, Arkansas
GSK Investigational Site
Bakersfield, California
GSK Investigational Site
Beverly Hills, California
GSK Investigational Site
Burbank, California
GSK Investigational Site
Campbell, California
GSK Investigational Site
Cerritos, California
GSK Investigational Site
El Centro, California
GSK Investigational Site
Fairfield, California
GSK Investigational Site
La Mesa, California
GSK Investigational Site
Laguna Hills, California
GSK Investigational Site
Los Angeles, California
GSK Investigational Site
Los Angeles, California
GSK Investigational Site
Oceanside, California
GSK Investigational Site
Petaluma, California
GSK Investigational Site
Poway, California
GSK Investigational Site
Riverside, California
GSK Investigational Site
Sacramento, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
San Jose, California
GSK Investigational Site
Santa Ana, California
GSK Investigational Site
Santa Barbara, California
Showing 40 of 308 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.